eMedevents
  • 135382+ Medical Conferences
  • 251 Specialties
  • 10409 Organizers
  • 150724 Speakers
  • 155 Countries
  • 4521 Cities
45127+
CME Conference Registrations Sold
Home  >  Speakers  >  Jagat Kanwar
Jagat Kanwar

Jagat Kanwar

    BSc, MSc, PhD
Professor | Burwood, Victoria    Australia
Biotechnology, Immunology And Microbiology
Immunology, Biotechnology,...More
Speaking at 2 events

Biography :

Professor Kanwar is the group leader and laboratory head of Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research in School of Medicine, Faculty of Health at Deakin University. His earlier research (for nearly a decade in New Zealand) has focused on studying pathophysiology and devising new treatments mainly for cancer and chronic inflammatory diseases. Prof. Kanwar is currently working on nanotechnology/nanomedicine based protein/peptide, aptamers and his research approach employs monotherapy (gene therapy, immunotherapy) and combinational therapy with commercially available chemotherapeutic agents including LNA-aptamers (RNA/DNA), peptides and other biomolecules such as siRNA, miRNA, aptamers, proteins, siRNA, miRNA and their chimera (LNA-aptamer chimera with siRNA/miRNA delivery for targeting expression of survivin (the validated anti-cancer target), HIF-1 and apoptotic signalling molecules’ in cancer and chronic inflammation.

We are discovering novel and safe targeted nanomedicine based nano-nutraceuticals for cancers, autoimmune disorders and inflammatory diseases. We also vested the molecular diagnosis including role of a non-invasive exosomes in blood, inflammatory sites and cancer tissues. Our research focused on cancer and inflammatory autoimmune diseases aims to investigate the underlying mechanisms involved in regeneration, apoptosis, autophagy and inflammation by targeting the production of cytokines, chemokines, oxygen radicals and matrix metalloproteinase. Our research also aims to investigate the nanotherapeutics encapsulating peptides, LNA modified aptamers/miRNAs/siRNA in vivo models. We have made significant progress in field of osteoarthritis, atherosclerosis, myocardial infarction, ocular inflammations, corneal haze, age related macular degeneration, glaucoma and ocular drug delivery. Apart from these we also work on microfluidic and Lab-on-a-Chip devices techniques for cancer cells as well as stem cell capture, disease specific biomarkers and exosomes.

**************************
*** * **** ****
   
For speaker's contact information - Contact us

Specialties

Biotechnology, Immunology and Microbiology

Interested Topics

Immunology, Biotechnology, Nanomedicine, Molecular Biomedical, Pathophysiology, Cancer, Chronic Inflammatory Diseases, Monotherapy, Autoimmune Disorders, Inflammatory Diseases, Molecular Diagnosis, Cytokines, Chemokines, Osteoarthritis, Atherosclerosis, Myocardial Infarction

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message